Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation

OBJECTIVES: To compare the clinical effects of Osimertinib and Gefitinib in the treatment of non-small cell lung (NSCLC) complicated with epidermal growth factor receptor (EGFR) gene mutation. METHODS: We retrospectively analyzed the clinical data of 102 patients with advanced NSCLC and EGFR gene mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofeng, Zhai, Zhanqiang, Zhu, Youcai, Zhou, Haiou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378400/
https://www.ncbi.nlm.nih.gov/pubmed/35991226
http://dx.doi.org/10.12669/pjms.38.6.5456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378400/
https://www.ncbi.nlm.nih.gov/pubmed/35991226
http://dx.doi.org/10.12669/pjms.38.6.5456

Ejemplares similares